Results for the quarter and year ended March,2026
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alpa Laboratories reported audited standalone revenue of Rs 10,581 lakhs for FY26, down from Rs 11,164 lakhs in FY25, representing a ~5.2% revenue decline. Profit after tax stood at Rs 1,495 lakhs compared to Rs 1,968 lakhs in the prior year, a ~24% decline. The company operates in the single segment of Drugs & Chemicals. The statutory auditor C.H. Padliya & Co. issued an unmodified opinion on both standalone and consolidated financial statements. Other income included unrealized profit from fair value appreciation of investments. The board also appointed new internal auditor (M/s S. S. Gandhi & Associates) and cost auditor (M/s Sudeep Saxena & Associates) for FY27.
Revenue and profit declined year-on-year due to lower operating performance and reduced other income from investment gains. The clean audit opinion provides comfort on financial reporting quality despite the earnings contraction.